Company Profile
Chengdu Henghui Pharmaceutical Co., Ltd. is located in Chengdu Wenjiang Cross-Strait Science and Technology Park. We specialize in customer synthesis of APIs, intermediates, and in process development. We are committed to research and develop the APIs and intermediates with technical barriers and high value-added. We have equipped with many kinds of laboratory equipments, including HPLC, digital melting point apparatus, digital polarimeter, UV spectrophotometer, etc. We have 2 laboratories for kilo-scale synthesis of compounds needed by our customers with the shortest time. We pay a lot of attention to train technical personals all the time, and we have a vibrant, well-trained young team. We are making progress all the time, and we have developed dozens of products. Depend on advanced equipment and strict management, we will provide high quality products and service to every customer.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
6-bromo-[1,2,4]triazolo[1,5-a]pyridine |
6-BROMO-[1,2,4]TRIAZOLO[1,5-A]PYRIDINE;6-Bromo[1,2,4]triazolo[1,5-a]pyridine 96%;6-Bromo[1,2,4]triazolo[1,5-α]pyridine;6-BroMo[1,2,4]triazolo[1,...;[1,2,4]Triazolo[1,5-a]pyridine,6-broMo- |
356560-80-0 | - / ≥98% | Inquiry |
ABT-199 |
Benzamide,4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-;4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide;ABT 199;GDC 0199;Venetoclax;Venclexta;Venclyxto;RG 7601;RG7601;RG-7601 |
1257044-40-8 | Inquiry | |
AC 55541 |
(2E)-2-[1-(3-Bromophenyl)ethylidene]α-(benzoylamino)-3,4-dihydro-4-oxo-1-phthalazineaceticacidhydrazide;AC 55541;(2E)-2-[1-(3-Bromophenyl)ethylidene] α-(benzoylamino)-3,4-dihydro-4-oxo-1-phthalazineacetic acid hydrazideAC55541;AOB2796;alpha-(Benzoylamino)-3,4-dihydro-4-oxo-1-phthalazineacetic acid (2E)-2-[1-(3-bromophenyl)ethylidene]hydrazide |
916170-19-9 | Inquiry | |
AMG319 |
3-Quinolinemethanamine,7-fluoro-α-methyl-N-9H-purin-6-yl-2-(2-pyridinyl)-,(αS)-;(αS)-7-Fluoro-α-methyl-N-9H-purin-6-yl-2-(2-pyridinyl)-3-quinolinemethanamine;AMG 319;N-[(1S)-1-[7-Fluoro-2-(2-pyridinyl)-3-quinolinyl]ethyl]-9H-purin-6-amine;ACP 319;1395408-86-2 |
1608125-21-8 | - / ≥98% | Inquiry |
ARRY-380,Irbinitinib,ONT-380 |
4,6-Quinazolinediamine,N6-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-;N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4,6-quinazolinediamine;ARRY 380;ONT 380;Tucatinib;Tukysa |
937263-43-9 | - / 98% | Inquiry |
AZD7986 |
AZD7986;brensocatib;1802148-05-5;INS1007;AZD 7986;AZD-7986;(S)-N-((S)-1-cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)phenyl)ethyl)-1,4-oxazepane-2-carboxamide;UNII-25CG88L0BB;25CG88L0BB;CHEMBL3900409 |
1802148-05-5 | - / 98% | Inquiry |
Binimetinib (MEK-162, ARRY-162, ARRY-438162) |
1H-Benzimidazole-6-carboxamide,5-[(4-bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-;5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide;Binimetinib;ARRY 438162;ARRY 162;MEK 162;Mektovi;1073666-70-2;1201685-05-3;1417448-81-7 |
606143-89-9 | Inquiry | |
Canagliflozin hemihydrate |
Cagliflozin heMihydrate;Canagliflozin hydrate (2:1);Canagliflozin heMihydrate;D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]Methyl]-4-Methylphenyl]-, hydrate (2:1);Canagliflozin heMihydrates;(2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol Hemihydrate;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol hydrate (2:1);Cageline |
928672-86-0 | - / ≥99% | Inquiry |
CEP-33779 |
[8-(4-Methylsulfonylphenyl)[1,2,4]triazolo[1,5-a]pyridin-2-yl][3-(4-methylpiperazin-1-yl)phenyl]amine;N-[3-(4-Methyl-1-piperazinyl)phenyl]-8-[4-(methylsulfonyl)phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-amine;[1,2,4]Triazolo[1,5-a]pyridin-2-amine, N-[3-(4-methyl-1-piperazinyl)phenyl]-8-[4-(methylsulfonyl)phenyl]-;N-(3-(4-Methylpiperazin-1-yl)phenyl)-8-(4-(methylsulfonyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridi;N-[3-(4-methylpiperazin-1-yl)phenyl]-8-(4-methylsulfonylphenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine |
1257704-57-6 | Inquiry | |
CHIR-090 |
CHIR 090;CHIR-090;CHIR090;N-{(1s,2r)-2-Hydroxy-1-[(Hydroxyamino)carbonyl]propyl}-4-{[4-(Morpholin-4-Ylmethyl)phenyl]ethynyl}benzamide;CHEMBL260091;N-[(2S,3R)-3-hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl]-4-[2-[4-(morpholin-4-ylmethyl)phenyl]ethynyl]benzamide;N-((2S,3R)-3-Hydroxy-1-(hydroxyamino)-1-oxobutan-2-yl)-4-((4-(morpholinomethyl)phenyl)ethynyl)benzamide;C90 |
728865-23-4 | - / ≥98% | Inquiry |
Coelenterazine |
Imidazo[1,2-a]pyrazin-3(7H)-one,6-(4-hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-8-(phenylmethyl)-;6-(4-Hydroxyphenyl)-2-[(4-hydroxyphenyl)methyl]-8-(phenylmethyl)imidazo[1,2-a]pyrazin-3(7H)-one;Coelenterazine;Preluciferin;Preluciferin (Watasenia);Luciferin (Oplophorus);Luciferin;Coelenterazin;NanoFuel;Watasenia preluciferin;Coelenterazine ntv;Native coelenterazine;Coelenterazine luciferin;57683-96-2 |
55779-48-1 | Inquiry | |
Defactinib |
Defactinib;VS 6063;VS6063;VS-6063;Defactinib(PF-04554878);N-methyl-4-(4-((3-(N-methylmethan-3-ylsulfonamido)pyrazin-2-yl)methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)benzamide;N-methyl-4-((4-(((3-(N-methylmethylsulfonamido)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamideDefactinib(PF-04554878)(VS-6063);N-Methyl-4-[[4-[[[3-[methyl(methylsulfonyl)amino]-2-pyrazinyl]methyl]amino]-5-(trifluoromethyl)-2-pyrimidinyl]amino]benzamide |
1073154-85-4 | - / ≥98% | Inquiry |
Emapunil |
9H-Purine-9-acetamide,N-ethyl-7,8-dihydro-7-methyl-8-oxo-2-phenyl-N-(phenylmethyl)-;N-Ethyl-7,8-dihydro-7-methyl-8-oxo-2-phenyl-N-(phenylmethyl)-9H-purine-9-acetamide;Emapunil;AC 5216;XBD 173;1186335-03-4 |
226954-04-7 | - / ≥98% | Inquiry |
EPZ-015666 |
EPZ015666;(S)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-6-(oxetan-3-ylamino)pyrimidine-4-carboxamide;GSK3235025;GSK-3235025;N-[(2S)-3-(3,4-Dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl]-6-(3-oxetanylamino)-4-pyrimidinecarboxamide;N-[(2S)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]-6-(oxetan-3-ylamino)pyrimidine-4-carboxamide |
1616391-65-1 | - / ≥98% | Inquiry |
EW-7197 |
N-(2-fluorophenyl)-5-(6-methyl-2-pyridinyl)-4-[1,2,4]triazolo[1,5-a]pyridin-6-yl-1H-imidazole-2-methanamine;NOV-1301;TEW-7197;N-[[4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl]methyl]-2-fluoroaniline;CPD3325-A5;N-(2-Fluorophenyl)-5-(6-methyl-2-pyridinyl)-4-[1,2,4]triazolo-[1,5-a]pyridin-6-yl-1H-imidazole;1H-Imidazole-2-methanamine, N-(2-fluorophenyl)-5-(6-methyl-2-pyridinyl)-4-[1,2,4]triazolo[1,5-a]pyridin-6-yl- |
1352608-82-2 | - / ≥98% | Inquiry |
Fevipiprant |
Fevipiprant;Fevipipran;NVP-QAW039;Fevipiprant(NVP-QAW039);QAW039;Fevipiprant (QAW039);2-Methyl-1-[[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl]-1H-pyrrolo[2,3-b]pyridine-3-acetic acid;CS-2449 |
872365-14-5 | - / 98% | Inquiry |
Galeterone |
Androsta-5,16-dien-3-ol,17-(1H-benzimidazol-1-yl)-,(3β)-;(3β)-17-(1H-Benzimidazol-1-yl)androsta-5,16-dien-3-ol;VN/124-1;VN 124;Galeterone;TOK 001;Galaterone;TK-001 |
851983-85-2 | Inquiry | |
Granisetron |
1H-Indazole-3-carboxamide,1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-;1H-Indazole-3-carboxamide,1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-,endo-;9-Azabicyclo[3.3.1]nonane,1H-indazole-3-carboxamide deriv.;1-Methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide;Granisetron;BRL 43694;BRL 43964;Kevatril;endo-Granisetron;Sustol;APF 530;Sancuso;121061-98-1;2407911-98-0 |
109889-09-0 | - / ≥99% | Inquiry |
GSK163090 |
GSK 163090 |
844903-58-8 | Inquiry | |
Icotinib |
[1,4,7,10]Tetraoxacyclododecino[2,3-g]quinazolin-4-amine,N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-;N-(3-Ethynylphenyl)-7,8,10,11,13,14-hexahydro[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine;Icotinib;BPI 2009H;1640118-92-8 |
610798-31-7 | Inquiry |
CONTACT INFORMATION
Sign In for Details